QA: NeuBase Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001173281_2023_NeuBase_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001173281, NeuBase Therapeutics Inc.

  xvar xval
0 AssetsCurrent 24,648,665
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,156,851
3 remainder_Assets 5,887,913
4 LiabilitiesCurrent 4,166,385
5 LiabilitiesNoncurrent 5,335,164
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,869,747
9 ResearchAndDevelopmentExpense 21,448,592
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -458,111
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 32,693,429
1 Liabilities 9,501,549
2 Expenses 33,318,339
3 Revenues 0
4 StockholdersEquity 23,191,880
5 NetIncome -33,776,450
6 ComprehensiveNetIncome -33,776,450
7 BaseVar 37,985,714
8 EconomicCapitalRatio 0.290

Edgar->Model Mapping

Feature Distribution

Change over Time